Early Access — free while we kick the tires
EdgarHawk

Todd Pendleton

SVP, Chief Marketing Officer

Officer

Latest: CMO selling · May 2026

2 filings analyzed · 1 company · Latest 2026-05-27

Companies

Company Buys Sells Direction
Dolby Laboratories, Inc. DLB 0 3 Net selling

Activity

May 2026
high
Sell
11,876 shares
$647,857
Significance 6/10

Todd Pendleton (SVP, CMO) sells 11,876 DLB shares at $54.55; stock -27.7% from 52-week high, 2 of 2 prior DLB sales were 90-day well-timed.

Todd Pendleton sold 11,876 shares for $647,857.18, reducing his holding by -22.3% to 41,480 shares post-transaction. The sale occurred at $54.55, while the stock currently trades at $55.66 and has declined -27.7% from its 52-week high of $77.00. Within his prior trades at Dolby Laboratories specifically, 2 of 2 prior sells (on 2025-02-19 and 2024-02-28) were well-timed at the 90-day mark, with negative subsequent returns of -3.5% and -2.9% respectively. His cross-ticker track record shows a 100.00% 90-day well-timed rate across 3 prior sells with an average 90-day return of -5.6%, suggesting a pattern of selling ahead of stock declines. The current stock weakness (-12.5% over 30 days, -14.9% over 90 days) and position in the broader 52-week drawdown warrant monitoring of whether this sale represents consistent timing discipline or reflects a shift in his asset-allocation strategy.

February 2025
high
Sell
18,121 shares
$1,517,668
Significance 5/10

SVP/CMO Pendleton Todd sold 18,121 shares of DLB at $83.75 on 2025-02-19, reducing stake by 32.7%; stock now $81.57.

Pendleton Todd, Chief Marketing Officer, executed a substantial open-market sale of 18,121 shares at $83.75, reducing his holdings from 55,411 to 37,290 shares—a -32.7% reduction in stake. The sale price of $83.75 sits near the 52-week range midpoint ($66.75–$87.32) and above the current price of $81.57, positioning the sale at a relatively favorable exit point. Across his prior open-market activity in Dolby (2 prior DLB sales in 2024 and 2023), Todd achieved mixed timing results, with 1 of 2 sales proving well-timed at the 90-day horizon; his cross-ticker track record shows an average 90-day return of -0.5% post-sale with a 50.00% well-timed rate. The company's fundamentals show a -2.0% annual revenue decline and a P/E of 29.77, with net income of $67.8M on revenue of $357.0M in the latest quarter. The magnitude of this disposition—nearly one-third of his stake, valued at $1,517,668.18—warrants investor attention to whether broader strategic or valuation concerns are reflected in the executive team's holding patterns.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access